查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2016122

真實世界數據解決方案市場報告：按組件、治療領域、最終用戶和地區分類（2026-2034 年）

Real-World Evidence Solutions Market Report by Component, Therapeutic Area, End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 135 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球真實世界證據（RWE）解決方案市場規模達20億美元。 IMARC Group預測，到2034年，該市場規模將達到38億美元，2026年至2034年的複合年成長率為7.01%。

真實世界證據 (RWE) 指的是透過真實世界數據 (RWD) 獲得的關於醫療產品使用及其潛在獲益和風險的臨床證據。它透過各種研究設計和分析方法生成，包括隨機對照試驗、大型簡單試驗、實踐試驗和觀察性研究。 RWE 能夠深入了解患者族群中真實的臨床治療模式，包括劑量、藥物順從性、治療順從性、仿單標示外用藥以及療效與安全性之間的平衡。此外，由於 RWE 能夠幫助研究人員識別臨床試驗的潛在患者、制定合適的納入標準，從而設計出更完善的試驗前研究，因此全球對 RWE 解決方案的需求正在成長。

真實世界證據（RWE）解決方案市場的發展趨勢：

對真實世界證據（RWE）解決方案的需求日益成長，以獲取關於新產品安全性和有效性的準確清晰信息，這是推動市場發展的主要因素之一。此外，當患有複雜疾病和合併症的患者使用產品時，對這類解決方案的需求也在不斷成長，以檢測不同的反應、亞組影響以及產品價值。同時，快速發展的醫療產業也在推動市場成長。此外，RWE中先進分析和技術解決方案的日益普及，旨在加速臨床開發、商業化、創新並改善醫療結果，這對市場產生了積極影響。此外，許多國家正在採取各種政府舉措，以促進RWE解決方案的使用，從而支持藥物和疫苗的有效性。此外，醫療保健模式從以數量為基礎轉向以價值為基礎的轉變，為行業投資者提供了極具吸引力的成長機會。此外，日益成長的數位化和以患者為中心的虛擬醫療的普及也推動了對RWE解決方案的需求。此外，癌症、肥胖症和糖尿病等慢性疾病的全球盛行率也不斷上升。這導致藥物研發進程延誤加劇，研發成本上升，進而推動了市場成長。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球真實世界數據解決方案市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依組件分類

  • 臨床領域數據
  • 保險索賠數據
  • 患者主導的數據
  • 藥房數據
  • 其他

第7章 市場區隔：依治療領域分類

  • 腫瘤學
  • 免疫學
  • 神經病學
  • 心血管疾病
  • 其他

第8章 市場區隔：依最終用戶分類

  • 製藥和醫療設備公司
  • 醫療費用支付方
  • 醫療服務提供方
  • 其他

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 SWOT 分析

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • Aetion Inc.
    • Clinigen Limited
    • Flatiron Health
    • ICON plc
    • IQVIA Inc.
    • Optum, Inc.
    • Oracle Corporation
    • Parexel International（MA）Corporation
    • SAS Institute Inc.
    • Syneos Health
    • Thermo Fisher Scientific Inc.
Product Code: SR112026A6149

The global real-world evidence solutions market size reached USD 2.0 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 3.8 Billion by 2034, exhibiting a growth rate (CAGR) of 7.01% during 2026-2034.

Real-world evidence (RWE) refers to clinical evidence about the use and potential benefits or risks of medical products via real-world data (RWD). It can be produced via different study designs or analyses, including randomized trials, big simple trials, pragmatic trials, and observational studies. It provides insight into real-world treatment patterns in patient groups, including dosing, compliance, adherence, off-label use, and the balance between efficacy and safety. As it can also assist researchers in discovering possible patients and developing correct inclusion criteria for clinical trials, which can help them design better pre-trial studies, there is a rise in the demand for RWE solutions around the world.

REAL-WORLD EVIDENCE SOLUTIONS MARKET TRENDS:

The growing demand for RWE solutions to get precise and clear information about the safety and efficacy of new products represents one of the key factors driving the market. Moreover, there is a rise in the demand for these solutions to detect varied reactions, product subpopulation effects, and product value when utilized by complex and comorbid patients. This, along with the burgeoning healthcare industry, is propelling the growth of the market. Additionally, the growing utilization of advanced analytics and technological solutions in RWE for clinical development, commercialization, speed innovation, and accelerating improvements in healthcare outcomes is positively influencing the market. Besides this, there are various initiatives undertaken by governments of several countries to promote the use of RWE solutions, which provide the efficacy of drugs and vaccines. This, coupled with a shift from volume to value-based care, is offering lucrative growth opportunities to industry investors. Apart from this, the growing adoption of digitalization and patient-centered virtual care is catalyzing the demand for RWE solutions. Furthermore, there is an increase in the prevalence of chronic diseases, such as cancer, obesity, and diabetes, across the globe. In line with this, the rising delays in drug development and the subsequent increase in development costs are bolstering the growth of the market.

KEY MARKET SEGMENTATION:

Breakup by Component:

  • Clinical Settings Data
  • Claims Data
  • Patient-Powered Data
  • Pharmacy Data
  • Others

Breakup by Therapeutic Area:

  • Oncology
  • Immunology
  • Neurology
  • Cardiovascular Disease
  • Others

Breakup by End User:

  • Pharmaceutical and Medical Device Companies
  • Healthcare Payers
  • Healthcare Providers
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

COMPETITIVE LANDSCAPE:

The report provides a comprehensive analysis of the competitive landscape in the global real-world evidence solutions market with detailed profiles of all major companies, including:

  • Aetion Inc.
  • Clinigen Limited
  • Flatiron Health
  • ICON plc
  • IQVIA Inc.
  • Optum, Inc.
  • Oracle Corporation
  • Parexel International (MA) Corporation
  • SAS Institute Inc.
  • Syneos Health
  • Thermo Fisher Scientific Inc.

KEY QUESTIONS ANSWERED IN THIS REPORT

1. What was the size of the global real-world evidence solutions market in 2025?

2. What is the expected growth rate of the global real-world evidence solutions market during 2026-2034?

3. What are the key factors driving the global real-world evidence solutions market?

4. What has been the impact of COVID-19 on the global real-world evidence solutions market?

5. What is the breakup of the global real-world evidence solutions market based on the component?

6. What is the breakup of the global real-world evidence solutions market based on the therapeutic area?

7. What is the breakup of the global real-world evidence solutions market based on the end user?

8. What are the key regions in the global real-world evidence solutions market?

9. Who are the key players/companies in the global real-world evidence solutions market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Real-World Evidence Solutions Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Component

  • 6.1 Clinical Settings Data
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Claims Data
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Patient-Powered Data
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Pharmacy Data
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Therapeutic Area

  • 7.1 Oncology
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Immunology
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Neurology
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Cardiovascular Disease
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Pharmaceutical and Medical Device Companies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Healthcare Payers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Healthcare Providers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Aetion Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Clinigen Limited
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
    • 14.3.3 Flatiron Health
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 ICON plc
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 IQVIA Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Optum, Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Oracle Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Parexel International (MA) Corporation
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 SAS Institute Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 SWOT Analysis
    • 14.3.10 Syneos Health
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Thermo Fisher Scientific Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio

List of Figures

  • Figure 1: Global: Real-World Evidence Solutions Market: Major Drivers and Challenges
  • Figure 2: Global: Real-World Evidence Solutions Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Real-World Evidence Solutions Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Real-World Evidence Solutions Market: Breakup by Component (in %), 2025
  • Figure 5: Global: Real-World Evidence Solutions Market: Breakup by Therapeutic Area (in %), 2025
  • Figure 6: Global: Real-World Evidence Solutions Market: Breakup by End User (in %), 2025
  • Figure 7: Global: Real-World Evidence Solutions Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Real-World Evidence Solutions (Clinical Settings Data) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Real-World Evidence Solutions (Clinical Settings Data) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Real-World Evidence Solutions (Claims Data) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Real-World Evidence Solutions (Claims Data) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Real-World Evidence Solutions (Patient-Powered Data) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Real-World Evidence Solutions (Patient-Powered Data) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Real-World Evidence Solutions (Pharmacy Data) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Real-World Evidence Solutions (Pharmacy Data) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Real-World Evidence Solutions (Other Components) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Real-World Evidence Solutions (Other Components) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Real-World Evidence Solutions (Oncology) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Real-World Evidence Solutions (Oncology) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Real-World Evidence Solutions (Immunology) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Real-World Evidence Solutions (Immunology) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Real-World Evidence Solutions (Neurology) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Real-World Evidence Solutions (Neurology) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Real-World Evidence Solutions (Cardiovascular Disease) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Real-World Evidence Solutions (Cardiovascular Disease) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Real-World Evidence Solutions (Other Therapeutic Areas) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Real-World Evidence Solutions (Other Therapeutic Areas) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Real-World Evidence Solutions (Pharmaceutical and Medical Device Companies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Real-World Evidence Solutions (Pharmaceutical and Medical Device Companies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Global: Real-World Evidence Solutions (Healthcare Payers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Global: Real-World Evidence Solutions (Healthcare Payers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Global: Real-World Evidence Solutions (Healthcare Providers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Global: Real-World Evidence Solutions (Healthcare Providers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Global: Real-World Evidence Solutions (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Global: Real-World Evidence Solutions (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: North America: Real-World Evidence Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: North America: Real-World Evidence Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: United States: Real-World Evidence Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: United States: Real-World Evidence Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Canada: Real-World Evidence Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Canada: Real-World Evidence Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Asia-Pacific: Real-World Evidence Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Asia-Pacific: Real-World Evidence Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: China: Real-World Evidence Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: China: Real-World Evidence Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Japan: Real-World Evidence Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Japan: Real-World Evidence Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: India: Real-World Evidence Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: India: Real-World Evidence Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: South Korea: Real-World Evidence Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: South Korea: Real-World Evidence Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Australia: Real-World Evidence Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Australia: Real-World Evidence Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Indonesia: Real-World Evidence Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Indonesia: Real-World Evidence Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Others: Real-World Evidence Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Others: Real-World Evidence Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Europe: Real-World Evidence Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Europe: Real-World Evidence Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Germany: Real-World Evidence Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Germany: Real-World Evidence Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: France: Real-World Evidence Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: France: Real-World Evidence Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: United Kingdom: Real-World Evidence Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: United Kingdom: Real-World Evidence Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Italy: Real-World Evidence Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Italy: Real-World Evidence Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Spain: Real-World Evidence Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Spain: Real-World Evidence Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Russia: Real-World Evidence Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Russia: Real-World Evidence Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Others: Real-World Evidence Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Others: Real-World Evidence Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Latin America: Real-World Evidence Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Latin America: Real-World Evidence Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Brazil: Real-World Evidence Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: Brazil: Real-World Evidence Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 78: Mexico: Real-World Evidence Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 79: Mexico: Real-World Evidence Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 80: Others: Real-World Evidence Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 81: Others: Real-World Evidence Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 82: Middle East and Africa: Real-World Evidence Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 83: Middle East and Africa: Real-World Evidence Solutions Market: Breakup by Country (in %), 2025
  • Figure 84: Middle East and Africa: Real-World Evidence Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 85: Global: Real-World Evidence Solutions Industry: SWOT Analysis
  • Figure 86: Global: Real-World Evidence Solutions Industry: Value Chain Analysis
  • Figure 87: Global: Real-World Evidence Solutions Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Real-World Evidence Solutions Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Real-World Evidence Solutions Market Forecast: Breakup by Component (in Million USD), 2026-2034
  • Table 3: Global: Real-World Evidence Solutions Market Forecast: Breakup by Therapeutic Area (in Million USD), 2026-2034
  • Table 4: Global: Real-World Evidence Solutions Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 5: Global: Real-World Evidence Solutions Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Real-World Evidence Solutions Market: Competitive Structure
  • Table 7: Global: Real-World Evidence Solutions Market: Key Players